Skip to main content
Loading ResearchHub…
References for Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease | ResearchHub - ResearchHub